Dow Down 0.32% Nasdaq Down 0.62%

Xencor, Inc. (XNCR)

-NasdaqGM
12.25 Down 0.64(4.97%) Apr 29, 4:00PM EDT
Prev Close:12.89
Open:12.81
Bid:N/A
Ask:15.40 x 300
1y Target Est:23.25
Beta:N/A
Next Earnings Date: 2-May-16XNCR Earnings announcement
Day's Range:12.04 - 12.87
52wk Range:9.89 - 24.82
Volume:171,331
Avg Vol (3m):247,037
Market Cap:497.13M
P/E (ttm):N/A
EPS (ttm):-0.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XNCRDown 4.97%497.13M
ABBVDown 0.33%98.68B
GSKDown 1.04%103.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):44.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.06
Quarterly EPS Est (Mar-16) :-0.27
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback